Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Barnet Dulaney Perkins Eye Center - First in the Southwest to Perform Visian Toric ICL Procedure

Barnet Dulaney Perkins Eye Center
Posted on: 01 Nov 18
Barnet Dulaney Perkins Eye Center - First in the Southwest to Perform Visian Toric ICL Procedure Barnet Dulaney Perkins Eye Center, an American Vision Partners affiliate, is the first practice in the Southwest to provide a new solution for patients with moderate to high levels of myopia and astigmatism ‒ in one simple procedure ‒ following FDA approval of STAAR Surgical's Visian Toric ICL.

PR Newswire

PHOENIX, Nov. 1, 2018

PHOENIX, Nov. 1, 2018 /PRNewswire-PRWeb/ -- Now Offering the Visian Toric ICL, an Innovative Solution to Myopia and Astigmatism
New treatment available at Barnet Dulaney Perkins Eye Center, Scott Perkins, MD

Phoenix, AZ, November 1, 2018 – Barnet Dulaney Perkins Eye Center, an American Vision Partners affiliate, is the first practice in the Southwest to provide a new solution for patients with moderate to high levels of myopia and astigmatism ‒ in one simple procedure ‒ following FDA approval of STAAR Surgical's Visian Toric ICL.

The Visian Toric ICL is an additive technology in which a lens is placed behind the iris and in front of the eye's crystalline lens to correct vision. This method works with the eye to not only restore clear and sharp vision but also to provide UV protection and excellent night vision. The Visian Toric ICL eliminates multiple surgical procedures by correcting astigmatism and myopia simultaneously. In a procedure that takes less than 30 minutes, the Visian Toric ICL enables doctors to treat more patients with astigmatism and myopia while preserving the corneal structure of the eye.

"The FDA's approval of STAAR's Visian Toric ICL provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom. We are pleased to partner with Barnet Dulaney Perkins Eye Center, the first practice in the Southwest to offer this technology to patients," said Jim Francese, Sr. Vice President Commercial Operations of STAAR Surgical.

FDA approval was based on results from the Visian Toric ICL clinical study, which reported that 98.4% of patients would have the Visian Toric ICL surgery again. Barnet Dulaney Perkins took part in the clinical study.

"As one of the most experienced Visian ICL surgeons in the country, I am excited to see the addition of Visian Toric ICL to my options for patients. At Barnet Dulaney Perkins Eye Center, we provide a personalized option for each patient to achieve the freedom from glasses and contact lenses, says Dr. Scott Perkins, a Founding Partner of Barnet Dulaney Perkins Eye Center.

For more information about Barnet Dulaney Perkins Eye Center and our expertise in Visian Toric ICL implantation visit https://www.goodeyes.com/implantable-contact-lenses/.

Visit https://staar.com/products/visian-icl to find out more about the Visian Toric ICL.

About Barnet Dulaney Perkins Eye Center
The doctors at Barnet Dulaney Perkins Eye Center are recognized leaders in providing state-of-the-art medical and surgical eye care in Arizona for more than 35 years. Doctors at Barnet Dulaney Perkins Eye Center use the most advanced technologies and techniques to treat patients at all stages of life. Comprehensive eye health services are provided by nationally recognized specialists in multiple fields of ophthalmology, including cataract surgery, vision correction, cornea, retina, glaucoma and oculoplastics. Patients can expect compassionate and convenient care from the doctors of any of the Barnet Dulaney Perkins Eye Center clinics. For more information, please visit goodeyes.com.

About American Vision Partners
American Vision Partners ("AVP") is one of the nation's largest and fastest growing eye care physician services organizations. AVP serves communities throughout Arizona and New Mexico with more than 110 nationally recognized doctors and 47 locations, including 24 ambulatory surgical centers. We partner with the most respected ophthalmology practices in the country and share a best-in-class management system, infrastructure and technology to provide the highest-quality patient care. Our partner practices, including Barnet Dulaney Perkins Eye Center, Southwestern Eye Center and M&M Eye Institute, each have been in practice for more than 35 years. For more information, visit http://www.AmericanVisionPartners.com.
---------------
1 Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser assisted in situ keratomileuses (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10): 1139-46
2 Shin, JY. Ahn, H. Seo, KY. Kim, EK. Kim, TK. Comparison of higher order aberrations after implantable collamer lens implantation and wavefront-guided LASIK in high myopia. J Refract Surg. 2012; 28(2): 106-111
3 Igarashi, A. Kamiya, K. Shimizu, K. Komatsu, M. Visual Performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileuses for high myopia. Am J Ophthalmol. 2009
4 Parkhurst, G. A prospective comparison of phakic collamer lenses and wavefront optimized laser-assisted in situ keratomileuses for correction of myopia. Clinical Ophthalmology 2016, 10:1209-1215
5 Alfonso, J. et al. Comparison of visual and refractive results of Toric Implantable Collamer Lens with bioptics for myopic astigmatism. Graefes Arch Clin Exp Ophthalmol (2013) 251:967–975
6 STAAR Surgical Visian Toric Implantable Collamer Lens PMA Supplement P030016 Ophthalmic Devices Advisory Panel, March 14, 2014

 

SOURCE Barnet Dulaney Perkins Eye Center

PR Newswire
www.prnewswire.com

Last updated on: 01/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.